Press Releases
-
SK bioscience-The International Vaccine Institute(IVI) jointly announce winners of the second Park M...2023.03.07 -
- ‘SKYZoster®, ´ the world second developed herpes zoster vaccine secures 54% of the South Korean ma...2023. 02. 28 -
· The additional investment for the ‘Global R&PD Center’ was confirmed by the board of directo...2023.02.08 -
-SK bioscience acquires ISO 27001 following successful completion of audit on 114 management items...2023.02.07 -
SK bioscience acquired an improved MSCI ESG rating from B->BBB in one year SK bioscience, a glob...2023.02.03 -
The world first cell culture-based influenza vaccine, ‘SKYCellflu®’ is approved for the first time i...2023.02.02 -
- SK bioscience shared a development history of the South Korea’s first COVID-19 vaccine at the Riya...2023.01.27 -
- Two biopharmaceutical experts join SK bioscience to strengthen the future strategies - With recru...2023.01.20 -
The world-second developed shingles vaccine ‘SKYZoster®’ is approved by the National Pharmaceutical ...2023.01.09 -
SK bioscience received A+ in Social and A in Environment and Governance categories in the first ESG ...2022.11.25 -
SK bioscience and IVI had a conference to discuss a cooperation against the next pandemic SK de...2022.11.17 -
SK bioscience explained the company’s sustainable growth strategy at investors meeting SK will...2022.11.01